Virtual Meeting on February 13 at 4 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Feb. 5, 2019--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in
vitro diagnostic technologies to the healthcare industry, will hold
its Annual Meeting of Shareholders on Wednesday, February 13, at
4 p.m. CT (5:00 p.m. ET), as a virtual meeting.
Gary Maharaj, chief executive officer, and Sue Knight, chair of the
board, will provide a brief update on business and key strategic
initiatives underway at the Company.
To attend the virtual meeting, go to www.virtualshareholdermeeting.com/SRDX19 at
least five minutes prior to the start of the meeting to log in. A
webcast replay of the Annual Meeting will be available until February
13, 2020.
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for
intravascular medical devices and a leading provider of chemical
components for in vitro diagnostic (IVD) immunoassay tests
and microarrays. Surmodics is pursuing highly differentiated
whole-product solutions that are designed to address unmet clinical
needs for its medical device customers and engineered to the most
demanding requirements. This key growth strategy leverages the
combination of the Company’s expertise in proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities. The Company mission remains to improve the
detection and treatment of disease. Surmodics is headquartered in Eden
Prairie, Minnesota. For more information, visit www.surmodics.com. The
content of Surmodics’ website is not part of this press release or part
of any filings that the company makes with the SEC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190205005285/en/
Source: Surmodics, Inc.
Tim Arens
952-500-7000
ir@surmodics.com
